Daniel Mendoza

Daniel Mendoza has a strong background in the field of biochemistry and research. Their most recent position is at Mission Bio, where they currently serve as the Director of Product Development. Prior to this role, they held the positions of Associate Director of Biochemistry R&D, Senior Manager of R&D, and Senior Scientist at the same company.

Before joining Mission Bio, Daniel worked at TOMA Biosciences as the Director of Assay Development and as a Senior Scientist. During their time at TOMA Biosciences, they contributed to the development of assays and conducted scientific research.

Daniel's earlier experience includes working as a Postdoctoral Fellow at the National Cancer Institute (NCI), where their research focused on the inflammatory transcription factor CEBPD and its potential as a biomarker for ER+ breast cancer. Daniel was responsible for coordinating multiple projects, organizing meetings with collaborators, and building teams.

Daniel's academic background includes a Ph.D. in Science from The University of Manchester. During their time as a Ph.D. graduate student, they conducted research on the Runx2-CBFB interaction as a potential therapeutic target for breast cancer with bone metastasis. Daniel also developed new laboratory protocols and executed experiments to meet project objectives.

Overall, Daniel Mendoza has a diverse range of experience in biochemistry, research and development, assay development, and product development.

Daniel Mendoza pursued their education in the field of Molecular Cancer Studies. From 2009 to 2012, they attended The University of Manchester, where they obtained a Doctor of Philosophy (Ph.D.) degree. Prior to that, from 2007 to 2009, they studied Genetics and Molecular Biology at CINVESTAV, IPN., earning a Master of Science (M.Sc.) degree.